Borhani HaghighiAEdgellRCCruz-FloresS. Vertebral artery origin stenosis and its treatment. J Stroke Cerebrovasc Dis. 2011;20:369–376.
2.
BrottTGHalperinJLAbbaraS.; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; American Stroke Association; American Association of Neuroscience Nurses; American Association of Neurological Surgeons; American College of Radiology; American Society of Neuroradiology; Congress of Neurological Surgeons; Society of Atherosclerosis Imaging and Prevention; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society of Neurointerventional Surgery; Society for Vascular Medicine; Society for Vascular Surgery; American Academy of Neurology and Society of Cardiovascular Computed Tomography. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. Stroke. 2011;42:e464–e540.
3.
CloudGCMarkusHS. Diagnosis and management of vertebral artery stenosis. Q J Med. 2003;96:27–54.
4.
SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke. 2004;35:1388–1392.
5.
EdgellRCZaidatOOGuptaR. Multicenter study of safety in stenting for symptomatic vertebral artery origin stenosis: Results from the Society of Vascular and Interventional Neurology Research Consortium. J Neuroimaging. 2013;23:170–174.
6.
PaluszekPPieniazekPDzierwaK. Long-term clinical outcomes after vertebral artery angioplasty in the prospective randomized STOVAST (STenting for Ostial Vertebral Artery STenosis) Trial population [abstract]. Eur Heart J. 2014:35(suppl 1):537.
7.
SongLLiJGuY. Drug-eluting vs. bare metal stents for symptomatic vertebral artery stenosis. J Endovasc Ther. 2012;19:231–238.
8.
StaymanANNogueiraRGGuptaR. A systematic review of stenting and angioplasty of symptomatic extracranial vertebral artery stenosis. Stroke. 2011;42:2212–2216.
9.
LangwieserNBuyerDSchusterT. Bare metal vs. drug-eluting stents for extracranial vertebral artery disease: a meta-analysis of nonrandomized comparative studies. J Endovasc Ther. 2014;21:683–692.
10.
ParkDWHongMKSuhIW. Results and predictors of angiographic restenosis and long-term adverse cardiac events after drug-eluting stent implantation for aorto-ostial coronary artery disease. Am J Cardiol. 2007;99:760–765.
11.
Al-LameeRIelasiALatibA. Comparison of long-term clinical and angiographic outcomes following implantation of bare metal stents and drug-eluting stents in aorto-ostial lesions. Am J Cardiol. 2011;108:1055–1060.
12.
LangwieserNProthmannSBuyerD. Safety and efficacy of different stent types for the endovascular therapy of extracranial vertebral artery disease. Clin Res Cardiol. 2014;103:353–362.
13.
MotarjemeAKeiferJWZuskaAJ. Percutaneous transluminal angioplasty of the vertebral arteries. Radiology. 1981;139:715–717.
ZamperiPColomboAAlmagorY. Results of coronary stenting of ostial lesions. Am J Cardiol. 1994;73:901–903.
17.
WernerMBräunlichSUlrichM. Drug-eluting stents for the treatment of vertebral artery origin stenosis. J Endovasc Ther. 2010;17:232–240.
18.
PaluszekPPieniazekPMusialekP. Symptomatic vertebral artery stenting with the use of bare metal and drug eluting stents. Adv Interv Cardiol. 2009;5:1–6.
19.
GengXHussainMDuH. Comparison of self-expanding stents with distal embolic protection to balloon-expandable stents without a protection device in the treatment of symptomatic vertebral artery origin stenosis: a prospective randomized trial. J Endovasc Ther. 2015;22:436–444.
20.
ChungSYLeeDHChoiJW. Use of self-expanding stents for the treatment of vertebral artery ostial stenosis: a single center experience. Korean J Radiol. 2010;11:156–163.
21.
LiZZhangYHongB. Stenting of symptomatic vertebral artery ostium stenosis with self-expanding stents. J Clin Neurosci. 2014;21:274–277.
22.
TangFWangQHuC. Use of the Szabo technique to guide accurate stent placement at the vertebral artery ostium. J Endovasc Ther. 2013;20:554–560.
23.
KrzanowskiM. Noninvasive diagnosis of extracranial and peripheral artery diseases. Pol Arch Intern Med. 1997;98:551–560.
24.
MusialekPPieniazekP. Restenosis after carotid artery stenting versus endarterectomy: the jury is still out!J Endovasc Ther. 2010;17:271–272.
25.
KantarciFMihmanliIAlbayramMS. Follow-up of extracranial vertebral artery stents with Doppler sonography. AJR Am J Roentgenol. 2006;187:779–787.
26.
MusialekP. Virtual histology intravascular ultrasound evaluation of atherosclerotic carotid artery stenosis: time for fully quantitative image analysis. J Endovasc Ther. 2013;20:589–594.
27.
PieniazekPMusialekPKablak-ZiembickaA. Carotid artery stenting with patient- and lesion-tailored selection of the neuroprotection system and stent type: early and 5-year results from a prospective academic registry of 535 consecutive procedures (TARGET-CAS). J Endovasc Ther. 2008;15:249–262.
28.
CremonesiAGieowarsinghSSpagnoloB. Safety, efficacy and long-term durability of endovascular therapy for carotid artery disease: the tailored-Carotid Artery Stenting Experience of a single high-volume centre (tailored-CASE Registry). EuroIntervention. 2009;5:589–598.
29.
PieniazekPMusialekPMotylR. Use of the Parodi Anti-Emboli System and transient subclavian steal for cerebral protection during emergent vertebral artery recanalization. J Endovasc Ther. 2004;11:511–516.
30.
PrzewlockiTKablak-ZiembickaAPieniazekP. Determinants of immediate and long-term results of subclavian and innominate artery angioplasty. Catheter Cardiovasc Interv. 2006;67:519–526.
31.
MusialekP. The CARENET multi-center all-comer trial using the CGuard™ micronet-covered carotid embolic prevention stent. Presented at LINC 2015; January 27–30, 2015; Leipzig, Germany.
http://linc2015.cloudcontrolled.com/media/15t_3_1058%20Musialek.pdf
. Accessed March 29, 2015.
32.
MusialekPMazurekATrystulaM. Novel PARADIGM in carotid revascularization: Prospective evaluation of All-comer peRcutaneous cArotiD revascularization In symptomatic and increased-risk asymptomatic carotid artery stenosis using CGuard™ Mesh-covered embolic prevention stent system. Abstract. EuroIntervention. 2015(PCR supplement). In press.
33.
Biondi-ZoccaiGAbbateAPeruzziM. Observations, trials, and meta-analyses: the life cycle of evidence-based endovascular therapy. J Endovasc Ther. 2014;21:693–696.
